サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451577

臨床診断市場レポート：検査、製品、エンドユーザー、地域別、2024-2032

Clinical Diagnostics Market Report by Test, Product, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 145 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
臨床診断市場レポート：検査、製品、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床診断市場規模は2023年に816億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて6.4%の成長率（CAGR）を示し、2032年までに1,438億米ドルに達すると予測しています。自己免疫疾患の増加、医療ツーリズムの増加傾向、特に先進ヘルスケアシステムを持つ国々における医療ツーリズムの増加傾向、個別化医療と診断への傾倒の高まりは、市場を推進している主な要因の一部です。

臨床診断とは、病気や病状の検出と特定に焦点を当てた医学の一分野を指します。ヘルスケア専門家が様々な検査、処置、評価を通じて幅広い疾患を正確に診断することを可能にします。医療上の意思決定に役立つ信頼性の高い情報をタイムリーに提供します。また、臨床医が患者の健康状態を評価し、治療プロトコルを計画し、さまざまな洗練された手法を駆使して予後を評価するために不可欠なデータを提供します。正確で早期の診断をサポートすることで、予防医療を促進し、治療効果をモニターすることで、ヘルスケアに不可欠な役割を果たしています。

ループスや関節リウマチのような自己免疫疾患の増加により、これらの疾患を早期に発見し、効果的に管理するための専門的な臨床診断の必要性が世界中で高まっています。さらに、特に先進的なヘルスケアシステムを持つ国々における医療ツーリズムの動向の高まりが、幅広い臨床診断検査の需要を喚起しています。さらに、慢性疾患や感染症の急増、高齢化社会の進展により、個別化医療や診断への関心が高まっていることも、市場にプラスの影響を与えています。これとは別に、専門的な診断センターの増加により、検査へのアクセスが容易になり、市場の成長に好影響を与えています。さらに、ヘルスケアプロバイダーがポイントオブケアで迅速かつ容易に患者を診断・モニタリングできるPOCT（Point of Care Testing）への嗜好が高まっていることも、市場に明るい展望をもたらしています。

臨床診断市場の動向と促進要因：

生活習慣病の増加

肥満、高血圧、糖尿病などの生活習慣病は世界的に増加傾向にあります。現代に蔓延する座りっぱなしのライフスタイルや食生活の乱れが、これらの疾患の大きな要因となっています。臨床診断は早期発見において重要な役割を果たし、予防措置やオーダーメイドの治療計画を容易にします。タイムリーな診断はしばしば救命につながり、ヘルスケアシステム全体の負担を軽減することができます。そのため、生活習慣病の増加は、これらの疾患を効果的に管理・抑制するための高度な臨床診断の必要性を高めています。

ヘルスケアに対する意識の高まり

インターネットや公衆衛生キャンペーンを通じて情報にアクセスしやすくなったこともあり、ヘルスケアや予防措置の重要性に対する一般市民の意識が高まっています。こうした意識の高まりは、予防ヘルスケアの一環として定期的な健康診断や診断検査を求める人々の割合の上昇につながっています。このような積極的な健康管理は、個人が自分の健康指標を理解し、潜在的な問題を早期に発見しようとするため、臨床診断の需要を大きく牽引しています。

高まる政府の取り組みと政策

世界各国の政府はヘルスケア・インフラに多額の投資を行い、定期的な検診を奨励する政策を推進しています。医療費補助、疾病の早期発見をターゲットとした公衆衛生キャンペーン、医学研究への資金提供の増加などのイニシアチブは、臨床診断の需要に直接的な影響を与えています。これらのプログラムは、診断サービスをより利用しやすくし、国民にとって手頃な価格にすることで、利用率を向上させる。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 臨床診断の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：検査別

  • 脂質パネル
    • 市場動向
    • 市場予測
  • 肝臓パネル
    • 市場動向
    • 市場予測
  • 腎臓パネル
    • 市場動向
    • 市場予測
  • 完全血算
    • 市場動向
    • 市場予測
  • 電解質検査
    • 市場動向
    • 市場予測
  • 感染症検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：製品別

  • 機器
    • 市場動向
    • 市場予測
  • 試薬
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院ラボ
    • 市場動向
    • 市場予測
  • 診断ラボ
    • 市場動向
    • 市場予測
  • ポイントオブケア検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Qiagen N.V.
    • Quest Diagnostics Incorporated
    • Siemens AG
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Clinical Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Clinical Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Clinical Diagnostics Market: Breakup by Test (in %), 2023
  • Figure 5: Global: Clinical Diagnostics Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Clinical Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Clinical Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Clinical Diagnostics (Lipid Panel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Clinical Diagnostics (Lipid Panel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Clinical Diagnostics (Liver Panel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Clinical Diagnostics (Liver Panel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Clinical Diagnostics (Renal Panel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Clinical Diagnostics (Renal Panel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Clinical Diagnostics (Complete Blood Count) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Clinical Diagnostics (Complete Blood Count) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Clinical Diagnostics (Electrolyte Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Clinical Diagnostics (Electrolyte Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Clinical Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Clinical Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Clinical Diagnostics (Other Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Clinical Diagnostics (Other Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Clinical Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Clinical Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Clinical Diagnostics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Clinical Diagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Clinical Diagnostics (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Clinical Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Clinical Diagnostics (Hospital Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Clinical Diagnostics (Hospital Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Clinical Diagnostics (Diagnostic Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Clinical Diagnostics (Diagnostic Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Clinical Diagnostics (Point-of-care Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Clinical Diagnostics (Point-of-care Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Clinical Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Clinical Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Clinical Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Clinical Diagnostics Industry: SWOT Analysis
  • Figure 86: Global: Clinical Diagnostics Industry: Value Chain Analysis
  • Figure 87: Global: Clinical Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Diagnostics Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Clinical Diagnostics Market Forecast: Breakup by Test (in Million US$), 2024-2032
  • Table 3: Global: Clinical Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Clinical Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Clinical Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Clinical Diagnostics Market: Competitive Structure
  • Table 7: Global: Clinical Diagnostics Market: Key Players
目次
Product Code: SR112024A5998

The global clinical diagnostics market size reached US$ 81.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 143.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032. The increasing number of autoimmune disorders, rising trend of medical tourism, particularly in countries with advanced healthcare systems, and the growing inclination towards personalized medicine and diagnostics are some of the major factors propelling the market.

Clinical diagnostics refer to a branch of medicine that focuses on detecting and identifying diseases and medical conditions. They allow healthcare professionals to accurately diagnose a wide range of illnesses through various tests, procedures, and evaluations. They provide reliable and timely information that aids in medical decision making. They also offer clinicians data that is vital for assessing patient health, planning treatment protocols, and making prognostic evaluations by employing a range of sophisticated methodologies. They play an essential role in healthcare by supporting accurate and early diagnoses, which facilitates preventive care and monitors the effectiveness of treatments.

The increasing number of autoimmune disorders like lupus and rheumatoid arthritis are driving the need for specialized clinical diagnostics to detect these conditions early and manage them effectively around the world. Moreover, the rising trend of medical tourism, particularly in countries with advanced healthcare systems, is catalyzing the demand for a wide range of clinical diagnostic tests. In addition, the growing inclination towards personalized medicine and diagnostics on account of the surging prevalence of chronic and infectious diseases and the increasing aging population, which is more prone to develop these medical conditions, is influencing the market positively. Apart from this, the rising number of specialized diagnostic centers ensure easier access to testing, which is favoring the growth of the market. Furthermore, the growing preference for point of care testing (POCT) that allows healthcare providers to diagnose and monitor patients at the point of care quickly and easily is creating a positive outlook for the market.

Clinical Diagnostics Market Trends/Drivers:

Increase in lifestyle diseases

The prevalence of lifestyle-related diseases like obesity, hypertension, and diabetes is on the upswing, globally. The sedentary lifestyles and poor dietary habits prevalent today contribute significantly to these conditions. Clinical diagnostics play a crucial role in early detection, facilitating preventive measures and tailored treatment plans. Timely diagnosis can often be lifesaving and can reduce the overall burden on healthcare systems. The rise in lifestyle diseases thereby elevates the need for advanced clinical diagnostics to manage and contain these conditions effectively.

Rise in healthcare awareness

The public is becoming more aware about the importance of healthcare and preventative measures, partly due to increased accessibility to information via the internet and public health campaigns. This increased awareness is leading to a higher rate of people seeking regular check-ups and diagnostic tests as part of preventative healthcare. Such proactive health management significantly drives the demand for clinical diagnostics, as individuals seek to understand their health metrics and catch potential issues early.

Growing government initiatives and policies

Governments worldwide are investing heavily in healthcare infrastructure and promoting policies that encourage regular medical screenings. Initiatives, such as subsidized healthcare, public health campaigns targeting early disease detection, and increased funding for medical research have a direct impact on the demand for clinical diagnostics. These programs make diagnostic services more accessible and affordable for the population, thereby driving up utilization rates.

Clinical Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global clinical diagnostics market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on test, product, and end user.

Breakup by Test:

Lipid Panel

Liver Panel

Renal Panel

Complete Blood Count

Electrolyte Testing

Infectious Disease Testing

Others

Lipid panel dominates the market

The report has provided a detailed breakup and analysis of the market based on the test. This includes lipid panel, liver panel, renal panel, complete blood count, electrolyte testing, infectious disease testing, and others. According to the report, lipid panel represented the largest segment. A lipid panel is a blood test that measures different types of fats and cholesterol levels in the blood, notably low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides. The test provides valuable information about the risk for heart disease of an individual and helps guide decisions about what treatment can be best if there is borderline or high risk.

A liver panel is a group of blood tests that evaluate the function of the liver and check for signs of liver damage or inflammation. The panel can include tests like alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin, among others. These results can aid in diagnosing liver diseases such as hepatitis or cirrhosis, and can also monitor the effects of certain medications on the liver.

The renal panel, also commonly known as a kidney panel, consists of various tests aimed at assessing kidney function. It often includes measurements of elements such as creatinine, blood urea nitrogen (BUN), and electrolytes like sodium, potassium, and chloride. The test is critical for diagnosing kidney diseases and for monitoring individuals who are at risk for kidney complications due to conditions like diabetes or high blood pressure.

Breakup by Product:

Instruments

Reagents

Others

Instruments holds the largest share in the market

A detailed breakup and analysis of the market based on the product has also been provided in the report. This includes instruments, reagents, and others. According to the report, instruments accounted for the largest market share. Instruments in clinical diagnostics refer to the specialized machinery and devices used to carry out various tests. These range from simple equipment like centrifuges, which separate different components of blood, to more complex machines like polymerase chain reaction (PCR) devices, which are used for DNA testing. Other instruments can include hematology analyzers for blood cell counts, biochemistry analyzers for measuring chemical substances in the blood, and imaging devices like X-rays or MRIs. These instruments are designed to be highly accurate and efficient, allowing for quick and reliable diagnoses.

Reagents are the chemical substances or compounds used in conjunction with diagnostic instruments to conduct tests. They interact with the samples of blood, urine, or tissue to produce measurable outcomes. Reagents can include antibodies used in immunoassays, chemical indicators, and enzymes. They are typically produced under strict quality control measures to ensure their efficacy and reliability.

Breakup by End User:

Hospital Laboratory

Diagnostic Laboratory

Point-of-care Testing

Others

Diagnostic laboratory dominates the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital laboratory, diagnostic laboratory, point-of-care testing, and others. According to the report, diagnostic laboratory represented the largest segment. Diagnostic laboratories are specialized facilities that focus solely on conducting diagnostic tests. They often serve multiple healthcare providers and may even accept samples from across different regions. These labs typically offer a wide array of tests, including specialized ones that a hospital lab might not provide. Diagnostic laboratories are crucial for outpatient care and ongoing monitoring of chronic conditions.

Point-of-care testing (POCT) refers to diagnostic tests that are conducted at or near the site where care is provided, usually by non-laboratory personnel. These tests are often simpler and quicker, designed to provide immediate results that can be acted upon without delay. Examples include glucose monitoring for diabetes patients and rapid strep tests in a primary care setting. POCT is invaluable in situations that require quick decision-making and immediate treatment.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest clinical diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing awareness about the benefits of clinical diagnostics among the masses represents one of the primary factors bolstering the market growth in the North American region. Moreover, the rising adoption of automation in medical testing is contributing to the market growth in the region. Besides this, the growing utilization of mobile health (m-health) applications is influencing the market positively.

Competitive Landscape:

The leading companies are integrating artificial intelligence (AI), machine learning (ML), and the internet of things (IoT) to interpret complex data sets, including medical images like X-rays and MRIs that can identify patterns and anomalies that can be missed by human eyes, thereby increasing the accuracy of diagnoses. They are also using genomic sequencing technologies like next-generation sequencing (NGS) that enable rapid and accurate identification of genetic markers for various diseases, which allows for personalized treatment plans that are more targeted and effective. Moreover, key players are utilizing liquid biopsy that allows for the detection of cancer cells or DNA fragments in the blood, which offers a less invasive alternative to traditional tissue biopsies.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Becton Dickinson and Company

bioMerieux SA

Bio-Rad Laboratories Inc.

Danaher Corporation

F. Hoffmann-La Roche AG

Qiagen N.V.

Quest Diagnostics Incorporated

Siemens AG

Sysmex Corporation

Thermo Fisher Scientific Inc

Recent Developments:

In 2022, Qiagen N.V. developed NeuMoDxHSV 1/2 Quant Assay for the quantification and differentiation of herpes simplex virus type 1 (HSV-1) DNA and/or herpes simplex virus type 2 (HSV-2) with approval from the European Commission.

In 2021, F. Hoffmann-La Roche AG acquired GenMark Diagnostics Inc. to access novel technology and test for pathogens with one patient sample.

In 2023, Abbott Laboratories recently signed a definitive agreement to acquire Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes.

Key Questions Answered in This Report

  • 1. What was the size of the global clinical diagnostics market in 2023?
  • 2. What is the expected growth rate of the global clinical diagnostics market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global clinical diagnostics market?
  • 4. What are the key factors driving the global clinical diagnostics market?
  • 5. What is the breakup of the global clinical diagnostics market based on the test?
  • 6. What is the breakup of the global clinical diagnostics market based on the product?
  • 7. What is the breakup of the global clinical diagnostics market based on the end user?
  • 8. What are the key regions in the global clinical diagnostics market?
  • 9. Who are the key players/companies in the global clinical diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test

  • 6.1 Lipid Panel
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Liver Panel
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Renal Panel
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Complete Blood Count
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Electrolyte Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Infectious Disease Testing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital Laboratory
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratory
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Point-of-care Testing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Qiagen N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sysmex Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis